History | About Us | 씨엔알리서치

History

C&R Research’s Bold Journey
Toward Becoming a Global Leader

C&R Research has pioneered the domestic clinical trial market,
established a unique and unrivaled position, and contributed to
the advancement of Korea’s pharmaceutical and clinical trial industries.
Today, our relentless challenge continues as we move forward as a global CRO.

1997 ~ 2000 Awakening the Korean CRO Industry

The Powerful First Step of Korea’s First CRO

July 1997Founded C&R Consulting
Mar 2000 Renamed to C&R Research Co., Ltd.

2001 ~ 2010 Setting the Standard
for Clinical Trials in Korea

Securing Market Leadership through Unrivaled Expertise

Mar 2001 Launched Regulatory Affairs services
May 2002Launched Data Management / Biostatistics services
Oct 2006Established Busan branch office
Nov 2006Launched QA / Audit services
Jun 2008First in Korea to receive the Frost & Sullivan Award
Oct 2008Selected as a Preferred Vendor by GSK
Apr 2009Selected as a Preferred Vendor by Novartis
May 2010Established C&R Academy
May 2010Selected as the Regional Director company representing Korea for PACRA
Jun 2010Designated as the leading CRO in the national initiative to foster domestic CRO capabilities for biosimilar clinical trials

2011 ~ 2015 Recognized as the
Premier Clinical Partner

Driving Growth through Unwavering Trust

May 2011COSMOS(C&R Optimal SAE Management Operating System)
Sep 2011Launched COSMOS (C&R Optimal SAE Management Operating System)
Sep 2011Established R&D Center as an in-house research institute (certified by the Korea Industrial Technology Association)
Nov 2011Selected as Partner CRO for the National Anti-Cancer New Drug Development Project
May 2012Formed a clinical trial partnership with AC Medical, Japan
Aug 2012Launched T-doc (EDC System)
Nov 2012Selected as the designated QA entrusted research institute by the Global Center of Excellence for Clinical Trials (Seoul National University Hospital Consortium)
Jun 2014Hosted the 1st C&R Symposium
Feb 2015 C&R Academy awarded the Minister of Food and Drug Safety Award for contributions to the advancement of the biopharmaceutical industry
Jun 2015 Completed new headquarters building in Daechi-dong, Gangnam, Seoul
Dec 2015Adopted Medidata Clinical Cloud solutions

2016 ~ 2020 Expanding Our Stage
to the World

Solid Internal Strength Driving External Growth

Apr 2016C&R Academy designated by the Ministry of Food and Drug Safety (MFDS) as an official clinical trial training institution
May 2016Launched LeadTrial, a web-based integrated platform
Aug 2016C&R Academy obtained ISO 9001 Quality Management System re-certification
Jan 2017Opened Singapore Incubating Center
Apr 2017Established C&R Healthcare Global Pte. Ltd. (Singapore subsidiary)
Oct 2017Launched LeadTrial CTMS
Aug 2018 Chairman Moon-Tae Yoon listed in Marquis Who’s Who
Apr 2019Executive Director Byung-Jin Ahn received the Health Industry Merit Award at the 6th Bio Korea
May 2019Chairman Moon-Tae Yoon honored with the Clinical Trials Merit Award on World Clinical Trials Day
Aug 2019Co-founded GC Cell Co., Ltd. with GC LabCell
Apr 2020Named “Top CRO in APAC 2020”
Oct 2020 Received KoNECT CRO Institutional Accreditation

2021 ~ 2024 Standing at the Heart of
Global Clinical Research

Leading the Global Market with Accumulated Expertise

Jan 2021Established Trial Informatics Co., Ltd.
May 2021Launched CsafeR, an electronic adverse drug reaction reporting system
Aug 2021Obtained ISO 9001 Quality Management System certification
Dec 2021Listed on KOSDAQ
Aug 2022Established C&R SMO Co., Ltd.
Aug 2022Selected as one of Korea’s “Top Jobs Companies” by the Ministry of Employment and Labor
Mar 2023Established ABC Bioscience Co., Ltd.
Oct 2023Established Thailand subsidiary
Nov 2023 Established U.S. subsidiary
Dec 2023Received KoNECT Innovative CRO Certification
Jun 2024Signed MOU with Microsoft Korea for “Advancing Clinical Trial Platform Using Microsoft Azure AI”
Dec 2024 Selected as a 2024 Work–Life Balance Excellence Company by the Ministry of Employment and Labor of Korea

2025 ~ Present Evolving with Data CRO

Beyond End-to-End for Future Clinical Trials

Apr 2025Signed global Phase 2 clinical trial contract with U.S.-based Advanced Clinical
Jun 2025Delivered keynote presentation at BIO USA 2025, representing Korea on “The Excellence of Korean Clinical Trials”
Jun 2025Formation of a fund with Yuanta Investment
July 2025Participation in MOHW 'Digital Bio Smart Clinical Support Platform' Project
Aug 2025Launch of the C&R Webinar
Nov 2025Participation in MOHW 'K-AI Drug Development Preclinical∙Clinical Model Development' Project
Nov 20252025 MOEL Fair Recruitment Excellence Awards, Chairman’s Award of HRDK
Dec 2025Web Award Korea 2025, Grand Prize in the Healthcare Services Category
Jan 2026Formed a preferred partnership with Equilab
Jan 2026Participation in KoNECT ‘K-CThub Database Development’ Project
Jan 2026Acquisition of ‘Mediplexus’, an RWD·RWE healthcare data company
Mar 2026Established Indonesia office
Apr 2026First in the Korean CRO industry to adopt AI Agents from Taimei Technology
May 2026Vietnam CRO Partnership Established
Jun 2026Awarded U.S. Confirmatory Clinical Trial for Korea's First DTx
Jul 2026Acquired EPSI Korea, a Japanese CRO

Now, we are creating a new future for global clinical trials.

From 4 to 500, our burning passion fueled
the journey - every success we’ve achieved is who we are.